Previous 10 | Next 10 |
DURHAM, N.C., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today amended its previously announced financial results for the three and nine months ended October 1, 2022. Due to the...
Boston, Massachusetts--(Newsfile Corp. - November 18, 2022) - Block & Leviton is investigating Bioventus, Inc. (NASDAQ: BVS) for potential securities law violations. Investors who have lost money in their Bioventus, Inc. investment should contact the firm to learn more about how the...
DURHAM, N.C., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the Company has filed a Form 12b-25, Notification of Late Filing for its Quarte...
Bioventus Inc. (BVS) Q3 2022 Earnings Conference Call November 08, 2022, 08:30 AM ET Company Participants Dave Crawford - VP of IR Ken Reali - CEO Mark Singleton - SVP and CFO Conference Call Participants Chase Knickerbocker - Craig-Hallum Capital Gro...
Shares of Bioventus (NASDAQ: BVS) fell 14% on Wednesday. The medical device company's stock closed on Tuesday at $3 a share, then opened on Wednesday at $2.90. The stock fell to as low as $2.25 before bouncing back a bit to $2.58 at the close. The stock is down more than 82% this ye...
Bioventus press release ( NASDAQ: BVS ): Q3 Non-GAAP EPS of $0.08 misses by $0.04 . Revenue of $137.1M (+25.9% Y/Y) misses by $4.49M . For the twelve months ending December 31, 2022, the Company now expects: Net sales of $527 million to $532 mill...
DURHAM, N.C., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for the three and nine months ended October 1, 2022. Q3 Financial Summary & Rec...
DURHAM, N.C., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the third quarter of fiscal year 2022 bef...
DURHAM, N.C., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, will present its spine procedural solutions portfolio at the North American Spine Society (NASS) me...
Summary Avanos Medical's recent acquisition of the TriVisc portfolio creates an interesting debate for those following the hyaluronic acid market. We are holders of a competing name and so it's interesting to compare both offerings. I also demonstrate there's been a disconnect...
News, Short Squeeze, Breakout and More Instantly...
DURHAM, N.C., July 30, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the second quarter of fiscal year 2024 before t...
2024-05-26 21:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...